Associations unite on therapeutic interchange. AACP News1987; 17(5): 1.
2.
Memorandum.American Medical Association, Chicago, IL: April 4, 1988.
3.
Statement on the pharmacy and therapeutics committee. Am J Hosp Pharm1959; 16: 122–3.
4.
Statement of guiding principles on the operation of the hospital formulary system. Am J Hosp Pharm1964; 21: 40.
5.
RUCKERTD, VISCONTIJ.How effective are drug formularies? A descriptive and normative study.Washington, DC: American Society of Hospital Pharmacists Research and Education Foundation, 1979.
6.
DOERINGPL, RUSSELLWL, MCCORMICKWC, KLAPPDL. Therapeutic substitution in the health maintenance organization outpatient environment. Drug Intell Clin Pharm1988; 22: 125–30.
7.
CHRISTENSENDB. Legal recognition of prescriptive authority for pharmacists. US Pharm1982; (Mar): H13–5.
8.
Substitution of prescription drugs. Revised code of Washington, 69.41.100-69.41.180, 1987.
9.
State chapters react to drug companies' positions on therapeutic interchange. Am J Hosp Pharm1987; 44: 2665, 2669.
10.
Therapeutic substitution by pharmacists limited to hospital setting in Wisconsin. Hosp Form1988; 23: 423, 426.
11.
RUFFENACHG.When druggists second-guess doctors. Wall Street Journal1988 May 9: section 2.
12.
Therapeutic substitution: most retail RPhs approve. Am Drug1987; 196(Dec): 18–20.
13.
MOSSINGHOFFGJ. Opposition to therapeutic interchange (letter). Am J Hosp Pharm1988; 45: 1065.
14.
PMA/Health Care Quality Alliance report on cost containment. FCC Reports1988; 50: 10 (T&G), March.
15.
JOHNSONRA, PELHAML, BYES.Joint letter to members of the Washington State Medical Association, Washington State Pharmacists Association, and Washington State Society of Hospital Pharmacists.Seattle, WA: March 1988.